Research Insights Episodes
Delve into discussions about recent research findings, emerging therapies, and expert insights that shape the understanding of multiple sclerosis.
192
May 3, 2021
Episode 192: Next-Generation MS Therapies with Dr. Michael Kornberg
In today's special episode of RealTalk MS, Dr. Michael Kornberg is going to give us a glimpse into emerging research and the future of MS treatments. So, if you'd like to peer into the not-too-distant future for a preview of the new MS therapies that will be available to you, this is the conversation you're looking for. Dr. Kornberg is an Assistant Professor of Neurology at the Johns Hopkins University School of Medicine and, in addition to his clinical work, Dr. Kornberg's lab is focused on id...
191
April 26, 2021
Episode 191: COVID-19 Vaccines and MS -- What You Need to Know Before You Go with Dr. Dorlan Kimbrough
With 200 million Americans having already received their COVID-19 vaccination, public health officials are warning that vaccine hesitancy is a growing challenge to our nation's ability to fully bounce back from the pandemic and resume something resembling the life we once knew. If what you're seeing and hearing about the COVID vaccines on social media or from well-meaning friends and family is making you nervous, my guest, Dr. Dorlan Kimbrough, is joining me to set the record straight. Dr. Kim...
190
April 19, 2021
Episode 190: MS Rehab in the Real World with Sally McAllister and Dr. Carol-Ann Nelson
Their website says that Destination Rehab takes an "innovative, out-of-the-box approach to physical therapy." This week, my guests are Sally McAllister and the founder of Destination Rehab, Dr. Carol-Ann Nelson. Sally is 70 years old and living with primary progressive MS. We're talking about how Sally's work with Dr. Nelson produced life-changing results. We're also talking about the first study that specifically measures the safety of the Pfizer-BioNtech COVID vaccine for people living with M...
189
April 12, 2021
Episode 189: Research on Sex Differences in MS Leads to Potential Treatment with Dr. Rhonda Voskuhl
MS affects almost 3 times as many women as men. Have you ever wondered why? When it comes to investigating sex differences in MS, my guest, Dr. Rhonda Voskuhl, has done more than just think about it. And her recent research may have uncovered an MS treatment for women undergoing menopause. Dr. Voskuhl is the President-elect of the International Organization for the Study of Sex Differences and the Director of the Multiple Sclerosis Program at UCLA. We're also talking about the potentially game...
188
April 5, 2021
Episode 188: Managing Your Cognitive Health in MS with Dr. Victoria Leavitt
More than half of all the people living with MS will develop problems with cognition. And while experiencing cognitive dysfunction can be challenging and frustrating, these kinds of changes can also be frightening. Joining me to talk about things you can do to better manage cognitive changes and preserve healthy cognition is neuroscientist and neuropsychologist, Dr. Victoria Leavitt. We're also talking about the encouraging results from a small clinical trial that tested stem cell therapy to t...
187
March 29, 2021
Episode 187: Progressive MS Research, Treatment, and Rehabilitation with Dr. Kathy Zackowski and Dr. Daniel Ontaneda
About 80% of the people with relapsing-remitting MS will eventually be diagnosed with secondary progressive MS. At that point, their remissions stop and their MS symptoms continue to worsen. And about 15% of the people diagnosed with MS are diagnosed from the beginning with primary progressive MS. So identifying ways to optimally treat progressive MS is a priority. Joining me with updates on progressive MS research, treatment, and rehabilitation are Dr. Kathy Zackowski and Dr. Daniel Ontaneda. ...
184
March 8, 2021
Episode 184: MS Awareness Week with Tracey Cooper-Harris and Sarah Quezada
It's MS Awareness Week and we're talking with two remarkable women, Sarah Quezada and Tracey Cooper-Harris, who are living their lives out loud, refusing to let MS define them. We're also inviting you to participate in the first-ever RealTalk MS Listener Survey (and be entered into a drawing for a $100 Amazon Gift Card!). We'll share research announced at the recent ACTRIMS Forum that explores whether we may be headed toward Cognitive-Dominant MS. We're also talking about how the National MS ...
182
Feb. 22, 2021
Episode 182: COVID-19 Vaccine Myth-Busting with Dr. Scott Newsome
If you spend more than a minute on social media it can seem like there's more misinformation about the COVID-19 vaccines than there is legitimate, fact-based information. And I've heard it said that if you repeat a lie enough, it becomes the truth. So we're doing some major COVID-19 vaccine myth-busting with Dr. Scott Newsome. Dr. Newsome is an Associate Professor of Neurology and Director of Neurosciences Consultation and Infusion Center at Johns Hopkins Medicine. He also serves as the Co-Dire...
178
Jan. 25, 2021
Episode 178: Diet and MS with Dr. Ilana Katz Sand
Paleo...Wahls...Swank...Mediterranean...intermittent fasting. Is there such a thing as "The MS Diet"? Joining me to offer an expert opinion about diet and MS is Dr. Ilana Katz Sand, the Associate Director of the Corinne Goldsmith Dickinson Center for MS and Co-Director of the Center's Wellness Program. Dr. Katz Sand's recent and current research studies include a clinical trial of dietary interventions for MS and exploring the role of the gut microbiome in MS. Dr. Katz Sand is also a member of ...
177
Jan. 18, 2021
Episode 177: Dr. Nancy Sicotte Answers Your Questions About the COVID-19 Vaccines and MS
As Chair of the National MS Society's National Medical Advisory Committee, Dr. Nancy Sicotte led the expert task force that the MS Society convened to develop the COVID-19 vaccine guidance for people living with MS. Dr. Sicotte is returning to RealTalk MS to answer your questions about the vaccine and MS. Dr. Sicotte is a Professor and Chair of the Department of Neurology at Cedars-Sinai Medical Center in Los Angeles, where she's also the Director of the Multiple Sclerosis and Neuroimmunology P...